Mortality News and Research

RSS

Alzheimer's disease: $14.5 trillion burden on global economy by 2050

Study estimates that Alzheimer's disease and other dementias will cost the global economy $14.5 trillion by 2050, disproportionately impacting high-income countries. Researchers call for urgent global action to mitigate this rising economic burden.

4 Sep 2024

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

3 Sep 2024

Research reveals impact of heatwaves on perinatal deaths in sub-Saharan Africa

Heatwaves in sub-Saharan Africa are predicted to become more common due to climate change. A new study by researchers at Karolinska Institutet and others, published in Nature Medicine, reveals a worrying correlation between high temperatures in the final week of pregnancy and an increased risk of stillbirth and early neonatal mortality.

3 Sep 2024

UCSF favors pricey doctoral program for nurse-midwives amid maternal care crisis

One of California's two programs for training nurse-midwives has stopped admitting students while it revamps its curriculum to offer only doctoral degrees, a move that's drawn howls of protest from alumni, health policy experts, and faculty who accuse the University of California of putting profits above public health needs.

3 Sep 2024

Hormonal treatment could delay biological aging among postmenopausal females

Hormone treatment in postmenopausal women is associated with lower biological aging discrepancies, particularly among those with lower socioeconomic status.

3 Sep 2024

European Society of Cardiology highlights underrecognized link between obesity and heart disease

Obesity is a key factor in cardiovascular disease, prompting the ESC to recommend comprehensive strategies for prevention and management to reduce health risks.

3 Sep 2024

UNICEF issues emergency tender for mpox vaccine procurement

UNICEF today announced that it has issued an emergency tender for the procurement of mpox vaccines. Vaccines can play a critical role in containing the mpox outbreak which was declared a public health emergency by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO).

2 Sep 2024

$FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction$

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Finerenone reduced heart failure (HF) events and cardiovascular death in patients with HF and mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Complete revascularization proves effective for older STEMI patients in first 4 years

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Fasting before cardiac catheterization not necessary, study finds

There was no difference in complications in patients who fasted or did not fast before cardiac catheterization procedures requiring conscious sedation, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide, a once-weekly dual agonist, outperforms long-acting insulin in reducing HbA1c, body weight, and improving cardiovascular markers in Type 2 diabetes patients.

2 Sep 2024

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

OCEANIC-AF trial reveals inferiority of asundexian to apixaban for stroke prevention

Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Rising resting heart rate over the years linked to shorter lifespan, study show

Study finds that increases in resting heart rate over time significantly raise mortality risk, underscoring heart rate as a key factor in lifespan determination.

1 Sep 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

Triple-pill combination GMRx2 outperforms standard care in lowering blood pressure

New research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill - known as GMRx2 - was superior to a high-quality standard care treatment plan at lowering blood pressure in patients with uncontrolled hypertension.

1 Sep 2024

RESHAPE-HF2 trial shows M-TEER as effective treatment for functional mitral regurgitation

Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to severe functional mitral regurgitation (FMR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Timing of blood pressure medication administration does not affect outcomes

Evening administration of blood pressure (BP)-lowering medications did not reduce the risk of cardiovascular events or death compared with morning administration, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

T-TEER shows promising outcomes in severe tricuspid regurgitation patients after one year

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after 1 year, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Mortality News and Research

Alzheimer's disease: $14.5 trillion burden on global economy by 2050

Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

Research reveals impact of heatwaves on perinatal deaths in sub-Saharan Africa

UCSF favors pricey doctoral program for nurse-midwives amid maternal care crisis

Hormonal treatment could delay biological aging among postmenopausal females

European Society of Cardiology highlights underrecognized link between obesity and heart disease

UNICEF issues emergency tender for mpox vaccine procurement

FINEARTS-HF trial shows finerenone benefits for heart failure with preserved ejection fraction

Complete revascularization proves effective for older STEMI patients in first 4 years

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

Fasting before cardiac catheterization not necessary, study finds

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

OCEANIC-AF trial reveals inferiority of asundexian to apixaban for stroke prevention

Rising resting heart rate over the years linked to shorter lifespan, study show

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

Triple-pill combination GMRx2 outperforms standard care in lowering blood pressure

RESHAPE-HF2 trial shows M-TEER as effective treatment for functional mitral regurgitation

Timing of blood pressure medication administration does not affect outcomes

T-TEER shows promising outcomes in severe tricuspid regurgitation patients after one year

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News